AustriaIn Austria, approximately a quarter of children and adolescents suffer from overweight or obesity, which increases their risk of developing serious health conditions such as type 2 diabetes, high blood pressure, fatty liver disease, cardiovascular issues, and orthopedic problems. These risks often persist into adulthood, along with psychological challenges like depression and social isolation due to bullying. As a result, more families are seeking weight-loss medications for their children. Two approved drugs—Saxenda for children aged six and older (daily dose) and Wegovy for those aged twelve and older (weekly dose)—are increasingly being used. At the Children’s PVE Donauinsel under the leadership of pediatrician Jasmin Voitl, over 750 children and adolescents with obesity have been treated since early 2025. The treatment approach is highly individualized, especially for children with autism or ADHD, who may experience satiety differently. Medications help patients feel fuller longer, but dosages are gradually increased based on individual responses. Families attend monthly check-ups, and while specific weight loss goals are avoided to prevent frustration, progress toward a health
Bias read (Center): The article discusses medical treatments for childhood obesity and does not present any political stance, controversy, or ideological framing. It focuses on health outcomes, treatment methods, and expert opinions without leaning toward any particular political perspective.
